SCHEMBL1398110

SCHEMBL1398110

CN1C(=O)CC(N2C=Nc3ccccc3C2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PKM P14618 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.36
ALOX12 P18054 1/20 0.34
LMNA P02545 1/20 0.34
HIF1A Q16665 1/20 0.34
CYP19A1 P11511 1/20 0.33
SIGMAR1 Q99720 2/20 0.32
CTSD P07339 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1398087 0.82 HIF1A (0.36) TSHRKMT2AALDH1A1HPGDPKM
SCHEMBL1398054 0.75 CRBN (0.44) TSHRKMT2AALDH1A1HPGDNPC1
SCHEMBL1398134 0.75 CTSD (0.42) TSHRKMT2AALDH1A1HPGDRAB9A
SCHEMBL26743418 0.73 ALDH1A1 (0.54) TSHRKMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL1398154 0.72 NPC1 (0.38) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL1398103 0.71 NPC1 (0.40) TSHRALDH1A1HPGDNPC1RAB9A
Bromide SCHEMBL1398089 0.71 NPC1 (0.38) HPGDNPC1RAB9ASMN1; SMN2CTSD
SCHEMBL28190128 0.70 NPC1 (0.50) KMT2AALDH1A1HPGDNPC1RAB9A
SCHEMBL28128653 0.69 NPC1 (0.41) HPGDNPC1RAB9ASMN1; SMN2CTSD
SCHEMBL5162159 0.69 CRBN (0.58) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957481-B1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION GRUENENTHAL GMBH (DE) 2011-03-02 EP claimed
US-20080293749-A1 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position GRUENENTHAL GMBH (DE) 2008-11-27 US claimed
EP-1957481-B1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION GRUENENTHAL GMBH (DE) 2011-03-02 EP disclosed
US-20080293749-A1 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position GRUENENTHAL GMBH (DE) 2008-11-27 US disclosed
EP-1957481-A1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION Grünenthal GmbH (DE) 2008-08-20 EP disclosed
WO-2007062817-A1 PYRROLIDIN(THI)ONES HETEROCYCLICALLY SUBSTITUTED IN 3-POSITION Grünenthal GmbH (DE) 2007-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293749-A1 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position TPMT, MALT1, THPO TSHR 299/4885KMT2A 1771/4885ALDH1A1 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.